Hanne Vestergaard

Hanne Vestergaard is a researcher in the Department of Clinical Research at the University of Southern Denmark, affiliated with the Research Unit of Haematology (Odense) and Odense University Hospital. Her work focuses on hematological malignancies, particularly mastocytosis and chronic myeloid leukemia (CML), with a strong emphasis on clinical trials and epidemiological studies.

Research Interests

• Mastocytosis epidemiology
• Treatment-free remission in CML
• Tyrosine kinase inhibitor discontinuation
• Health-related quality of life in oncology
• Hospitalization outcomes for hematological patients

Her recent publications highlight collaborations in international trials like EURO-SKI, analyzing prognostic factors for CML remission, and Danish nationwide studies on mastocytosis prevalence. She actively participates in conferences and interdisciplinary clinical initiatives.

Activities

• Co-author in 2024 Journal of Clinical Oncology EURO-SKI Trial
• Co-author in 2024 Leukemia quality-of-life studies
• Contributor to 2024 European Journal of Haematology mortality risk analysis

Press/Media

• 2024: Commentator on healthcare resource allocation
• 2024: Featured in public recognition of healthcare professionals